Izotropic Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IZOZF research report →
About the company
Izotropic Corporation is a medical technology company focused on bringing advanced diagnostic solutions for breast cancer to market. The firm develops and sells both a specialized breast CT imaging system and a 3D CT breast imaging platform, which are designed to facilitate earlier detection and more accurate diagnosis of breast cancer. Founded in 2016, the company's operations are headquartered in Surrey, Canada.
- CEO
- Robert Louis Thast
- IPO
- 2021
- Employees
- 5
- HQ
- Surrey, BC, CA
Price Chart
- Market Cap
- $13.31M
- P/E
- -7.23
- P/S
- 0.00
- P/B
- -3.52
- EV/EBITDA
- -9.47
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 48.20%
- ROIC
- 113.44%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,139,710 · -101.09%
- EPS
- $-0.05 · -84.48%
- Op Income
- $-2,102,838
- FCF YoY
- -7.38%
- 52W High
- $0.37
- 52W Low
- $0.12
- 50D MA
- $0.20
- 200D MA
- $0.21
- Beta
- 2.38
- Avg Volume
- 21.58K
Get TickerSpark's AI analysis on IZOZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IZOZF coverage
Recent articles, reports, and earnings notes.
No research on IZOZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IZOZF report →Similar companies
Peers in the same neighborhood.